Dexamethasone sodium phosphate sustained release (Taiwan Liposomal Company)
缓释型地塞米松磷酸钠悬浮注射液(台湾微脂体股份有限公司)
Report date: 2026/03/20 20:03:07
Base Information
Drug NameDexamethasone sodium phosphate sustained release (Taiwan Liposomal Company)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Liposome Company Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaiwan Liposome Company Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A